SEC 13F Intelligence

Bridge City Capital, LLC / AMPH

Bridge City Capital, LLC’s Amphastar Pharmaceuticals In Position

Does Bridge City Capital, LLC own Amphastar Pharmaceuticals In (AMPH)? Yes — 335.1K shares worth $7M (+1.82% of its 13F portfolio) as of Q1 2026, up from 235.5K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
335.1K
% of Portfolio
+1.82%
Quarters Held
12
currently held

Position History AMPH

Reported value by quarter
Q2 ’23: $1MQ2 ’23Q3 ’23: $1MQ4 ’23: $2MQ4 ’23Q1 ’24: $2MQ2 ’24: $2MQ2 ’24Q3 ’24: $3MQ4 ’24: $3MQ4 ’24Q1 ’25: $3MQ2 ’25: $3MQ2 ’25Q3 ’25: $4MQ4 ’25: $6MQ4 ’25Q1 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026335.1K$7M+1.82%
Q4 2025235.5K$6M+1.85%
Q3 2025136.3K$4M+0.97%
Q2 2025138.6K$3M+0.89%
Q1 2025115.9K$3M+1.01%
Q4 202470.1K$3M+0.69%
Q3 202471.1K$3M+0.95%
Q2 202448.9K$2M+0.66%
Q1 202434.8K$2M+0.56%
Q4 202334.5K$2M+0.83%
Q3 202322.7K$1M+0.53%
Q2 202322.8K$1M+0.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridge City Capital, LLC’s full portfolio or all institutional holders of AMPH.